Functional MRI Brain - CAM 761

GENERAL INFORMATION

It is an expectation that all patients receive care/services from a licensed clinician. All appropriate supporting documentation, including recent pertinent office visit notes, laboratory data, and results of any special testing must be provided. If applicable: All prior relevant imaging results and the reason that alternative imaging cannot be performed must be included in the documentation submitted. 

Where a specific clinical indication is not directly addressed in this guideline, medical necessity determination will be made based on widely accepted standard of care criteria. These criteria are supported by evidence-based or peer-reviewed sources such as medical literature, societal guidelines and state/national recommendations.

Policy
INDICATIONS FOR FUNCTIONAL BRAIN MRI1,2
Pre-Operative/Procedural Evaluation1

In the following where fMRI may have a significant role in the mapping of a lesion in relation to eloquent cortex (i.e., language, motor, sensory and visual centers) to determine the appropriateness of surgical intervention

  • Focal brain lesion (i.e., tumor or vascular malformation) for presurgical planning3,3,4,6
  • Pre-operative evaluation for epilepsy surgery7,8
  • Brain tumor for radiation treatment planning9,10

Post-Operative/Procedural Evaluation

  • Therapeutic follow-up. A documented medical reason must clearly explain the medical necessity for follow up (i.e., evaluation of post-treatment eloquent cortex).

Rationale
Functional MRI (fMRI) of the brain is a non-invasive imaging technique, using radio waves and a strong magnetic field, to image the brain activity of a patient prior to undergoing brain surgery for tumors or epilepsy. It is based on the increase in blood flow to the local vasculature when parts of the brain are activated and helps to determine the location of vital areas of brain function. fMRI images capture blood oxygen levels in parts of the brain that are responsible for perception, cognition, and movement allowing neurosurgeons to operate with less possibility of harming areas that are critical to the patient’s quality of life. fMRI is primarily used for presurgical planning, operative risk assessment and therapeutic follow-up.

Task vs Resting-State fMRI
During resting-state fMRI (rs-fMRI), unlike task-based functional MRI, the individual is not required11,12,13 to perform any specific task. This is beneficial for patients who have difficulty performing tasks, such as pediatric and certain neurologic or psychiatric patients. This technique has been well-utilized in research, and its clinical use is increasing considerably, especially in presurgical planning (e.g., mapping epileptic foci) and neuropsychiatric diseases. For the above indications, non-tasked based fMRI such as resting state fMRI can also be performed. 

fMRI as an alternative to the invasive Wada test and direct electrical stimulation — fMRI is considered an alternative to the Wada test and direct electrical stimulation as it is a non-invasive method for location of vital brain areas. The Wada test is used for the pre-operative evaluations of patients with brain tumors and seizures to determine which side of the brain is responsible for vital cognitive functions, e.g., speech and memory. It can assess the surgical risk of damaging the vital areas of the brain. The Wada test is invasive, involving an angiography procedure to guide a catheter to the internal carotid where a barbiturate is injected, putting one hemisphere of the brain to sleep. Direct electrical stimulation mapping is invasive requiring the placement of electrodes in the brain. The electrodes are used to stimulate multiple cortical sites in the planned area of resection to allow the surgeons to identify and mark which areas can be safely resected.14,15

fMRI and brain tumors — fMRI may significantly affect therapeutic planning in patients who have potentially resectable brain tumors. Due to its non-invasiveness, its relatively high spatial resolution, and its pre-operative results, fMRI is used before surgery in the evaluation of patients with brain tumors. fMRI may have a significant role in mapping lesions that are located in close proximity to vital areas of brain function (language, sensory motor, and visual). It can determine the precise spatial relationship between the lesion and adjacent functionally essential parenchyma, allowing removal of as much pathological tissue as possible during resection of brain tumors without compromising essential brain functions. fMRI provides an alternative to other invasive tests, such as the Wada test and direct electrical stimulation.16

fMRI and seizures — Brain fMRI can influence the diagnostic and therapeutic decisions of the seizure team, thereby affecting the surgical approach and outcomes. Brain surgery is often the treatment for patients with refractory epilepsy, especially patients with a single seizure focus. fMRI can be used to image and localize abnormal brain function in patients with seizures. fMRI can help determine brain functions (language, sensory motor, and visual) of areas bordering the lesion, resulting in better outcomes with less neurologic deficit.8

fMRI is increasingly being used to evaluate candidates for surgical treatment of intractable epilepsy (Phase 1 evaluation) and can aid in surgical decision-making. It can 1) help to improve functional outcome by enabling surgery that spares functional cortex, 2) guide surgical intervention by revealing when reorganization of function has occurred, and 3) show when abnormal cortex is also functionally active, and hence that surgery may not be the best option17,18

References

  1. American College of Radiology, American Society of Neuroradiology, Society for Pediatric Radiology. ACR–ASNR–SPR practice parameter for the performance of functional magnetic resonance imaging (fMRI) of the brain. American College of Radiology. Updated 2022. Accessed January 29, 2023. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/fmr-brain.pdf
  2. Kumar VA, Heiba IM, Prabhu SS, et al. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging. Jul 11 2020;20(1):47. doi:10.1186/s40644-020-00327-w
  3. Jiao Y, Lin F, Wu J, et al. Brain Arteriovenous Malformations Located in Language Area: Surgical Outcomes and Risk Factors for Postoperative Language Deficits. World Neurosurg. Sep 2017;105:478-491. doi:10.1016/j.wneu.2017.05.159
  4. Silva MA, See AP, Essayed WI, Golby AJ, Tie Y. Challenges and techniques for presurgical brain mapping with functional MRI. Neuroimage Clin. 2018;17:794-803. doi:10.1016/j.nicl.2017.12.008
  5. Stancanello J, Cavedon C, Francescon P, et al. BOLD fMRI integration into radiosurgery treatment planning of cerebral vascular malformations. Med Phys. Apr 2007;34(4):1176-84. doi:10.1118/1.2710326
  6. Vysotski S, Madura C, Swan B, et al. Preoperative FMRI Associated with Decreased Mortality and Morbidity in Brain Tumor Patients. Interdiscip Neurosurg. Sep 2018;13:40-45. doi:10.1016/j.inat.2018.02.001
  7. Benjamin CFA, Dhingra I, Li AX, et al. Presurgical language fMRI: Technical practices in epilepsy surgical planning. Hum Brain Mapp. Oct 2018;39(10):4032-4042. doi:10.1002/hbm.24229
  8. Janecek JK, Swanson SJ, Sabsevitz DS, et al. Language lateralization by fMRI and Wada testing in 229 patients with epilepsy: rates and predictors of discordance. Epilepsia. Feb 2013;54(2):314-22. doi:10.1111/epi.12068
  9. Kovács A, Tóth L, Glavák C, et al. Integrating functional MRI information into conventional 3D radiotherapy planning of CNS tumors. Is it worth it? J Neurooncol. Dec 2011;105(3):629-37. doi:10.1007/s11060-011-0633-2
  10. Wang M, Ma H, Wang X, et al. Integration of BOLD-fMRI and DTI into radiation treatment planning for high-grade gliomas located near the primary motor cortexes and corticospinal tracts. Radiat Oncol. Mar 8 2015;10:64. doi:10.1186/s13014-015-0364-1
  11. Lv H, Wang Z, Tong E, et al. Resting-State Functional MRI: Everything That Nonexperts Have Always Wanted to Know. AJNR Am J Neuroradiol. Aug 2018;39(8):1390-1399. doi:10.3174/ajnr.A5527
  12. J. K, A. G, L. T, K. T, S. F, R. G. National medicare trends in the utilization of fMRI. Neuroscience Informatics. March 2022 2022;2(1):100031. 
  13. Lee MH, Smyser CD, Shimony JS. Resting-state fMRI: a review of methods and clinical applications. AJNR Am J Neuroradiol. Oct 2013;34(10):1866-72. doi:10.3174/ajnr.A3263
  14. Binder JR. Functional MRI is a valid noninvasive alternative to Wada testing. Epilepsy Behav. Feb 2011;20(2):214-22. doi:10.1016/j.yebeh.2010.08.004
  15. Bizzi A, Blasi V, Falini A, et al. Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology. Aug 2008;248(2):579-89. doi:10.1148/radiol.2482071214
  16. Petrella JR, Shah LM, Harris KM, et al. Preoperative functional MR imaging localization of language and motor areas: effect on therapeutic decision making in patients with potentially resectable brain tumors. Radiology. Sep 2006;240(3):793-802. doi:10.1148/radiol.2403051153
  17. Liégeois F, Cross JH, Gadian DG, Connelly A. Role of fMRI in the decision-making process: epilepsy surgery for children. J Magn Reson Imaging. Jun 2006;23(6):933-40. doi:10.1002/jmri.20586
  18. Vakharia VN, Duncan JS, Witt J-A, Elger CE, Staba R, Engel Jr J. Getting the best outcomes from epilepsy surgery. Annals of Neurology. 2018;83(4):676-690.  doi:https://doi.org/10.1002/ana.25205

 

Coding Section

Codes Number Description
CPT 70554 Magnetic resonance imaging, brain, functional MRI; including test selection and administration of repetitive body part movement and/or visual stimulation, not requiring physician or psychologist administration 
  70555 Magnetic resonance imaging, brain, functional MRI; requiring physician or psychologist administration of entire neurofunctional testing 

Procedure and diagnosis codes on Medical Policy documents are included only as a general reference tool for each policy. They may not be all-inclusive.

This medical policy was developed through consideration of peer-reviewed medical literature generally recognized by the relevant medical community, U.S. FDA approval status, nationally accepted standards of medical practice and accepted standards of medical practice in this community, Blue Cross Blue Shield Association technology assessment program (TEC) and other nonaffiliated technology evaluation centers, reference to federal regulations, other plan medical policies, and accredited national guidelines.

"Current Procedural Terminology © American Medical Association. All Rights Reserved" 

History From 2014 Forward     

12/01/2023 Annual review, no change to policy intent. Updating policy for consistency.
12/06/2022 Annual review, no change to policy intent. Updating description and references.

12/01/2021 

Annual review, no change to policy intent. Updating references. 

12/01/2020 

Annual review, no change to policy intent. 

11/13/2019 

Interim review, reformatting entire policy for clarity and format. No change to policy intent. 

02/14/2019 

Annual review, no change to policy intent. Updating rationale and references. 

03/08/2018 

Annual review, no change to policy intent. Updating background, rationale and references. 

02/01/2017 

Annual review, no change to policy intent. Updating title, background, description, regulatory status, rationale and references. 

02/10/2016 

Annual review, no change to policy intent. Updating background, description, rationale and references. Adding regulatory status.

02/18/2015 

Annual review, no change to policy intent. Updated rationale and references. Added guidelines and coding. 

02/6/2014

Annual Review. Added related policies. Updated references, rationale and description. No change to policy intent.

Complementary Content
${loading}